The world’s first ever trial into microdosing LSD began on September 3rdthis year, after claims that regularly taking tiny doses of the drug can improve creativity and focus as well as lift depression. Microdosing has become increasing popular among young professionals, especially in the Californian tech world, where people work long hours in creative fields. The idea is they take one tenth of a dose of LSD every few days before work. The dose is too small to cause any of the typical psychedelic effects or hallucinations, but it is said to put users into a ‘flow state’, in which they are better able to focus and can increase inventiveness and creativity.
World’s First Trial
Of course, this is an illegal activity and so, studies into the effects of microdosing are difficult to organize and expensive to run. However, the Beckley Foundation, originally set up to research mind-altering substances, has found a way around current obstacles in order to complete the first ever placebo-controlled microdosing trial. Study leader Balazs Szigeti explains that they’ve recruited volunteers who currently microdose and have supplied them with dummy capsules, into which they put some genuine doses and some placebo doses.
The capsules are then placed into envelopes with QR codes and mixed up, so that the volunteer doesn’t know whether they are taking a placebo or the real thing. They scan the QR codes each time they take a dose, so that the researchers know which is which, and participants are shown the results at the end of the experiment. The participants then complete questionnaires and take part in online cognitive games in order to judge their increase (or lack thereof) of cognitive function and motivational drive.